Sponsored Symposia
Thursday, February 6, 2025
07:45-08:30
New & Emerging Therapies in the Management of Acne
Elena Netchiporouk
Scientist, RI-MUHC, Montreal General Hospital site
Infectious Diseases and Immunity in Global Health Program
Centre for Translational Biology
Assistant Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University
Department of Medicine, Division of Dermatology, MUHC
Assistant Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University
Department of Medicine, Division of Dermatology, MUHC
Learning Objectives
At the end of this session, participants will be able to:
1. Explain the pathophysiology, clinical features, and psychosocial impact of acne.
2. Establish a clinical diagnosis and apply the appropriate evidence-based treatment approach.
3. Counsel and manage patients with acne to optimize outcomes over the long term.
1. Explain the pathophysiology, clinical features, and psychosocial impact of acne.
2. Establish a clinical diagnosis and apply the appropriate evidence-based treatment approach.
3. Counsel and manage patients with acne to optimize outcomes over the long term.
Sponsored by Bausch Health
12:30-13:15
Pneumococcal Infections
Earl Rubin
Division Director, Pediatric Infectious Diseases Specialist, Montreal Children's Hospital, Montreal, QC
Learning Objectives
At the end of this session, participants will be able to:
1. To learn and understand Invasive Pneumococcal Disease (IPD) and its clinical manifestations
2. Review the history of vaccination prevention for IPD, both here in Quebec and across Canada
3. Review the new and upcoming changes to vaccination, with the recent approval and use of 3 new Pneumococcal Conjugate vaccines (PCVs).
1. To learn and understand Invasive Pneumococcal Disease (IPD) and its clinical manifestations
2. Review the history of vaccination prevention for IPD, both here in Quebec and across Canada
3. Review the new and upcoming changes to vaccination, with the recent approval and use of 3 new Pneumococcal Conjugate vaccines (PCVs).
Sponsored by Merck Canada Inc.